Editor's Note

When your stock loses 4% to a historic low when the broader market is up big, there may be trouble ahead. Somebody is dumping these shares after a big loss in Q1. What do they know that we do not?



NEW BULLISH Plays

No New Bullish Plays


NEW BEARISH Plays

QURE - UniQure - Company Profile

UniQure is a biopharmaceutical company, engages in the discovery, development, and commercialization of gene therapies in the Netherlands. The company offers Glybera, a gene therapy product for the treatment of patients with lipoprotein lipase deficiency. They have multiple drugs in development for a variety of illnesses.

In their recent earnings they reported a loss of 92 cents that missed estimates for a loss of 82 cents. Revenue of $4.3 million did beat estimates for $2.9 million. This is a very small company and since the ASCO conference their shares have been in crash mode.

Losses appear to be accelerating and they lost $22.69 million in Q1. Their market cap is only $204 million.

There was no gap open today despite the major gap higher in the market. They closed at a historic low at $8.20. They have only been public for 2 years and from the chart today it looks like they are going significantly lower. Normally when a stock hits the prior historic low there is a rebound or at least a pause. Neither occurred and that suggests it will go lower.

With a QURE trade at $8.00

Short QURE shares, initial stop loss $9.25.

No options recommended.